1. Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients
   Franziska Büscheck et al, 2020, Cancer Medicine CrossRef
2. BIRC3 and BIRC5: multi‐faceted inhibitors in cancer
   Raffaele Frazzi, 2021, Cell & Bioscience CrossRef
3. Survivin as a diagnostic and therapeutic marker for thyroid cancer
   Mohammad-Reza Mahmoudian-Sani et al, 2019, Pathology - Research and Practice CrossRef
4. Development of a novel lipid metabolism-based risk score model in hepatocellular carcinoma patients
   Wenjie Wang et al, 2021, BMC Gastroenterology CrossRef
5. Predictive significance of serum dipeptidyl peptidase-IV in papillary thyroid carcinoma
   Nan Zhang et al, 2019, Cancer Biomarkers CrossRef
6. Overexpression of survivin in pediatric Hodgkin lymphoma tumor cells: Characterization of protein expression and splice-variants transcription profile
   Mario Alejandro Lorenzetti et al, 2019, Experimental and Molecular Pathology CrossRef
7. Utilizing Three-Dimensional Culture Methods to Improve High-Throughput Drug Screening in Anaplastic Thyroid Carcinoma
   Kensey Bergdorf et al, 2022, Cancers CrossRef
8. Altered Expression of ESR1, ESR2, PELP1 and c-SRC Genes Is Associated with Ovarian Cancer Manifestation
   Monika Englert-Golon et al, 2021, International Journal of Molecular Sciences CrossRef
9. A review on protein markers of exosome from different bio-resources and the antibodies used for characterization
   Fengyan Deng et al, 2019, Journal of Histotechnology CrossRef